Latest Articles

Publication Date
Endometriosis: Fapohunda leads charge for compassion, policy reform - The Sun Nigeria

Endometriosis: Fapohunda leads charge for compassion, policy reform The Sun Nigeria

Published: March 4, 2026, 11:36 p.m.
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial - Cannabis Health News

Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial Cannabis Health News

Published: March 4, 2026, 9:33 p.m.
'I had never experienced pain like it': Why it's time we stopped telling women that this agony is normal... - Daily Mail

'I had never experienced pain like it': Why it's time we stopped telling women that this agony is normal... Daily Mail

Published: March 4, 2026, 7:54 p.m.
Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain - NOW Toronto

Endometriosis stole my ‘normal’ and gave me a lifetime of diagnoses and pain NOW Toronto

Published: March 4, 2026, 4:08 p.m.
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie - Barchart.com

Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie Barchart.com

Published: March 4, 2026, 1:30 p.m.
As Women Wait 7–10 Years for Diagnosis, PRM Expands - GlobeNewswire

As Women Wait 7–10 Years for Diagnosis, PRM Expands GlobeNewswire

Published: March 4, 2026, 1:16 p.m.
As Women Wait 7–10 Years for Diagnosis, PRM Expands Endometriosis Centers of Excellence to Three Major U.S. Cities - Yahoo Finance Singapore

As Women Wait 7–10 Years for Diagnosis, PRM Expands Endometriosis Centers of Excellence to Three Major U.S. Cities Yahoo Finance Singapore

Published: March 4, 2026, 1:16 p.m.
Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis marketscreener.com

Published: March 4, 2026, 11:51 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis lelezard.com

Published: March 4, 2026, 10:17 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - Bolsamania

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis Bolsamania

Published: March 4, 2026, 7:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!